A clinical trial to study the effects of a Polyherbal Siddha drug, Atthippattaiyathi Kasayam in patients with Type 2 Diabetes Mellitus (Mathumegam).
Phase 3
Completed
- Conditions
- Health Condition 1: null- Mathumegam (Type-2 Diabetes Mellitus)
- Registration Number
- CTRI/2014/11/005185
- Lead Sponsor
- national institute of siddha
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 40
Inclusion Criteria
Polyuria,
Nocturia,
Polydipsia,
Polyphagia,
Body pain,
Weight gain(obesity),
Tiredness,
Burning feet,
genital pruritus,
Diabetes defined as those patients with Fasting plasma glucose level 126 to 180 mg/dl,
2 hours postprandial plasma glucose level 200 to 300 mg/dl
Exclusion Criteria
IDDM,
Diabetic complications like microvascular and macrovascular complications etc,
Cardiac diseases,
Pulmonary diseases,
Renal diseases,
Thyroid dysfunctions,
Gestational diabetes,
Other endocrine abnormalities,
Patient who are not willing to give blood sample
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary outcome: <br/ ><br> The outcome is mainly assessed by comparing the pre and post treatment blood glucose level of the trial patient. <br/ ><br>Timepoint: 40 days
- Secondary Outcome Measures
Name Time Method secondary outcome is assessed by comparing the pre and post siddha and clinical parameters and investigation parameters like lipid frofile.Timepoint: 40 days